Trends in Bio/Pharma Facilities: Ken Gilmartin Gives His Perspective (INTERPHEX 2023)

Article
Conference|INTERPHEX

Wood CEO Ken Gilmartin gives his insight on what's currently in demand in terms of new bio/pharma manufacturing facilities.

Ken Gilmartin, CEO, Wood, gives his insight on what's currently in demand in terms of new bio/pharma manufacturing facilities. He emphasizes that a significant amount of capital is being invested in the United States for facilities, particularly in the large molecule and cell and gene therapy sectors.

For more INTERPHEX 2023 video content, check this page for updates.

Recent Videos
US tariff rate rising , trade policy , business graph and dollars banknote , tax calculation change | Image Credit: © janews094 - stock.adobe.com
Related Content
UAE flag waving in the sky, national symbol of UAE | Image Credit: © Freelancer - stock.adobe.com

Abu Dhabi Department of Health Reaches Strategic Agreements During US Mission

Patrick Lavery
June 20th 2025
Article

The department’s newly announced partnerships were part of a weeklong visit that included discussions held at BIO 2025.

How Changing Regulations Impact Pharmaceutical Film Coating Formulations (AAPS 2022)

How Changing Regulations Impact Pharmaceutical Film Coating Formulations (AAPS 2022)

Chris Spivey
November 29th 2022
Podcast

Allison Labriola, Senior Technical Sales Representative, at JRS Pharma is interviewed by the Editorial Director of Pharmaceutical Technology Chris Spivey about how the food industry is affecting the pharmaceutical industry.

A doctor in a white lab coat shaking hand showing symbol of medicine innovation, treatment, discovery and healthcare analysis. | Image Credit: © chadchai - stock.adobe.com

Geopolitical Shifts Change Nature of Pharma Partnerships

Patrick Lavery
May 28th 2025
Article

The concerns of industry experts expressed at INTERPHEX in April 2025 are still pertinent in an uncertain global political climate.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

GSK Previews Oral and Poster Abstracts for ATS International Congress

Patrick Lavery
May 5th 2025
Article

The company is presenting data related to its medications designed to advance the prevention and treatment of asthma and COPD.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Capsida Previews Its Oral and Poster Presentations for ASGCT 2025

Patrick Lavery
April 29th 2025
Article

The company’s exhibitions will be focused in the areas of its pipeline, proprietary capsid engineering, and manufacturing.

The show floor at INTERPHEX 2025. | Image Credit: © Patrick Lavery/PharmTech Group

Recapping INTERPHEX 2025: Pharma Looks Toward the Future

Patrick Lavery
April 4th 2025
Article

The yearly convention in New York City showcased new and emerging technologies and gave participating exhibitors a chance to unveil their strategies for the second half of the 2020s.